Rising demand for Nucleotide Analogss in the Food Beverage (FB) industry and increasing demand for dietary Nucleotide Analogss are some major factors driving market revenue growth 

Nucleotide Analogs Market size – USD 550.10 Million in 2021, Growth – CAGR of 5.9%, Trends – Increasing use of next-generation sequencing methods for studying viral pathogens 

The global Nucleotide Analogs Market size is expected to reach USD 926.18 Million in 2030 and register a revenue CAGR of 5.9%, according to the latest report by Reports and Data. Key factors, such as rising demand for Nucleotide Analogss in the Food Beverage (FB) industry and increasing demand for dietary Nucleotide Analogss are driving global market revenue growth. 

In addition, increasing Nucleotide Analogs application in various end-use industries such as pharmaceuticals, food beverage additives, animal feed additives, and diagnostic testing is driving revenue growth of the market. Growing customer consciousness of adverse effects of savory ingredients is estimated to spur demand for a Nucleotide Analogs-based flavoring agent. Moreover, advancements in methods is another factor anticipated to foster market revenue growth during the forecast period. Nucleotide Analogss are synthesized endogenously and have important effects on growth and development of cells with a high turnover rate such as those in the immune system and digestive tract. Nucleoproteins and nucleic acids, which are present in various amounts in many foods, such as lamb, liver, and mushrooms, are dietary sources of Nucleotide Analogss. Furthermore, increasing demand for Nucleotide Analogs-rich food items will drive revenue growth of the market between 2022 and 2030.

Get a sample of the report: https://www.reportsanddata.com/sample-enquiry-form/3368

Top Companies: Geneaid Biotech Ltd., MCLAB, ProMega Corporation, PurMaBiologics, QIAGEN, Takara Bio, Inc., Thermo Fisher Scientific, TransGen Biotech Co., Ltd., PolyOrg, Inc., Zymo Research Corporation, Trilink Biotechnologies, Inc., Meridian Bioscience, LGC Biosearch Technologies, BOC Sciences, Ajinomoto Co., Inc., Merck KGaA, PerkinElmer, Inc., and Jena Bioscience GmbH. 

Further Key Finding from the Report Suggestion:

• Based on technology, the TaqMan Allelic Discrimination segment was valued at USD 206.23 Million in 2021 and is expected to be valued at USD 325.37 Million by 2030, growing at a CAGR of 5.1% during the forecast period. Allelic discrimination assays are widely used in academic and research laboratories for genotyping frame shifts, point mutations, as well as small (six base pair length) insertions and deletions. TaqMan allelic discrimination assays use a TaqMan probe for detecting specific alleles in Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) samples. The assay enables researchers to rapidly detect allelic variations observed in samples of patients with genetic disorders. Furthermore, rising prevalence of viral diseases is expected to further increase demand of this assay, thereby driving revenue growth of this segment during the forecast period.
• Based on application, the molecular biology segment is projected to account for a significant revenue share over the forecast period. Diagnostics and treatment of human diseases have been facilitated by genomic technology developments. In genetics, introduction of molecular technology has led to development of novel approaches for diagnostic and predictive DNA analysis that are increasingly specific, quick, and trustworthy. In addition, production of nucleic acid analogues has become an important aspect of modern biology, due to potential application of these new biomarkers in genetic diagnosis and research. In the past decade, nucleic acids have been widely changed by substituting neutral or charged structures for phosphodiester linker or sugar-phosphodiester backbone. Several of these modified oligoNucleotide Analogss exhibit enhanced Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) affinity and binding characteristics. Locked Nucleic Acids (LNAs), also known as Bridging Nucleic Acids (BNAs) and Peptide Nucleic Acids (PNAs) are two prominent representations of this new form of oligomers.

Market Overview:

Consumers are placing a higher importance on sustainability and, as a result, are choosing items based on factors like circularity and carbon footprint. Furthermore, consumer concern about carbon emissions has prompted increased investment in renewable energy, energy efficiency, and transportation decarbonization. These developments have had considerable impact on chemical end sectors, particularly in the automobile and construction industries. COVID-19 has exacerbated the situation by lowering the automobile and construction industries (as well as many others) and disrupting current supply lines.

Download Summary: https://www.reportsanddata.com/download-summary-form/3368

The global Nucleotide Analogs Market is segmented into:

Product Outlook (Revenue, USD Million, 2019 - 2030)

• Laboratory Grade
  • DeoxyNucleotide Analogs Triphosphates (dNTPs)
    • Deoxyadenosine Triphosphate (dATP)
    • Deoxycytidine Triphosphate (dCTP)
    • Deoxyguanosine Triphosphate (dGTP)
    • Thymidine Triphosphate (dTTP)
  • Nucleoside Triphosphates (NTPs)
    • Adenosine Triphosphate (ATP)
    • Tetrahydrogen Triphosphate (CTP)
    • Guanosine-5’-Triphosphate (GTP)
    • Uridine Triphosphate (UTP)
  • Modified Nucleotide Analogss
    • Fluorescently-labeled Nucleotide Analogss
    • Biotin-labeled Nucleotide Analogss
    • Linker-modified Nucleotide Analogss
    • Cap Analog and Variants
  • Industry Grade
  • Food Grade

Concentration Outlook (Revenue, USD Million, 2019 - 2030)

• 2-5 mM
• 5-10 mM
• 10-25 mM
• 25-100 mM

Technology Outlook (Revenue, USD Million, 2019 - 2030)

• TaqMan Allelic Discrimination
• Gene Chips Microarrays
• SNP by Pyrosequencing
• Other Technologies

Application Outlook (Revenue, USD Million, 2019 - 2030)

• Pharmaceutical Research
• Diagnostic Application
• Molecular Biology
  • PCR
    • Reverse Transcriptase
    • DNA Labeling
    • Other Molecular Biology
  • Food and Beverage Additive
  • Animal Feed Additive
  • Other Applications

End-User Outlook (Revenue, USD Million, 2019 - 2030)

• Pharmaceutical and Biotechnology Companies
• Diagnostic Labs
• Academic and Research Institutes
• Other End-users

Regional Outlook:

• North America (U.S.A., Canada, Mexico)
• Europe (Italy, U.K., Germany, France, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Questions Addressed in the Report:

• What are the dominating factors that are influencing the growth of the industry?
• In the forecast period, which market segment is expected to rise the most?
• What are the risks and challenges that the industry is facing?
• In the coming years, which area is projected to dominate the market?
• Who are the major players in the market?
• What kind of strategic business plans have they made?

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/3368

Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.

Browse More Reports:

Low-E Glass Market https://www.reportsanddata.com/report-detail/low-e-glass-market

Nitrile Rubber Market https://www.reportsanddata.com/report-detail/nitrile-rubber-market

Infection Control Market https://www.reportsanddata.com/report-detail/global-infection-control-market

Metal Casting Market https://www.reportsanddata.com/report-detail/metal-casting-market

Plastic Decking Market https://www.reportsanddata.com/report-detail/plastic-decking-market

Read New Blogs:

https://www.reportsanddata.com/blog/top-textile-chemicals-manufacturers-in-the-world

https://www.reportsanddata.com/blog/top-10-paints-and-coatings-brands

https://www.reportsanddata.com/blog/industrial-wastewater-treatment

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkedIn | Twitter | Blogs | Insights

Read the innovative blog at https://www.reportsanddata.com/blogs

Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports